SCHEMBL22928253

SCHEMBL22928253

c1cc2[nH]nnc2cc1[C@@H]1CCNC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 2/20 0.46
▸ PDE4B Q07343 1/20 0.44
▸ CYP2D6 P10635 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ QDPR P09417 1/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ HTR1D P28221 1/20 0.38
▸ HTR1B P28222 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR1E P28566 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ HTR5A P47898 1/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ JAK3 P52333 1/20 0.37
▸ TLR9 Q9NR96 1/20 0.36
▸ TLR8 Q9NR97 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31110437 0.91 QDPR (0.47) QDPRTLR9TLR8TLR7
Hydrochloric Acid SCHEMBL31110482 0.89 QDPR (0.46) QDPRTLR9TLR8TLR7
SCHEMBL10948259 0.83 BACE1 (0.43) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL22609014 0.76 CHRNB2 (0.48) HTR3APDE4BCYP2D6SLC6A2SLC6A4
SCHEMBL22437864 0.72 TLR9 (0.64) TLR9TLR8TLR7
SCHEMBL22609013 0.70 CHRNB2 (0.48) HTR3APDE4BCYP2D6SLC6A2SLC6A4
SCHEMBL22608972 0.70 KDM4E (0.47) HTR3APDE4BCYP2D6SLC6A2SLC6A4
SCHEMBL142543 0.69 ULK1 (0.56) HTR6
SCHEMBL12455980 0.69 HTR3A (0.49) HTR3APDE4BCYP2D6SLC6A2SLC6A4
SCHEMBL22619204 0.69 HTR3A (0.49) HTR3APDE4BCYP2D6SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 HTR3A 123/4885PDE4B 616/4885CYP2D6 556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback